Supply of CE-SDS Kits (Capillary Electrophoresis – Sodium Dodecyl Sulfate Kits)

The contract entails the supply of CE-SDS kits designed for protein purity and size analysis using the ProteinSimple Maurice platform, ensuring precise and reproducible results critical for biopharmaceutical quality control. Each kit must include full traceability through a Certificate of Analysis and adhere strictly to FDA technical standards, reinforcing compliance with regulatory requirements for product integrity and safety. The procurement is structured as a subcontract under the NAICS code 325414, issued by the FDA Office of Acquisition and Grant Services within the Department of Health and Human Services, targeting vendors capable of meeting stringent analytical and documentation benchmarks. Proposals must be submitted by the deadline of August 7, 2026, at 7:30 PM, with the solicitation posted on August 1, 2026, allowing a six-day response window. The place of performance and specific location details are not specified, indicating flexibility in delivery logistics as long as compliance and quality standards are met. No set-aside provisions are indicated, making this opportunity open to all qualified suppliers. The contract emphasizes technical reliability, regulatory alignment, and documented quality assurance as non-negotiable elements for vendor selection.